Merck invests $169 million for selective PARP1 medication

October 31, 2023

AstraZeneca Expands AI-Powered Immuno-Oncology Research Partnership with Immunai

October 1, 2024

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

April 22, 2026

Must Read

Will AI Replace Traditional CRO Models in Clinical Research?

May 19, 2026

The New Competitive Advantage in Life Sciences: Real-Time Data Intelligence

May 19, 2026

Following FDA hold, Aardvark will examine phase 3 data early

May 19, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Alkermes Reports Positive Phase 3 Results for Lumryz in Idiopathic Hypersomnia

Good News For Enterprise As It Announces Phase 2 Cystic Fibrosis Victory

Lilly Studies Show Weight Loss Maintenance After Switching to Foundayo or Lower-Dose Zepbound

Inhibrx Reports Higher Response Rate for INBRX-106 and Keytruda in Midphase Head and Neck Cancer Trial

Novo Pens Deal With Cellular Intelligence to Advance Parkinson’s Cell Therapy

Bayer Expands Opthalmology Pipeline With $2.4B Perfuse Acquisition

Madrigal Licenses ARO-PNPLA3 from Arrowhead in Deal Worth Up to $1 Billion

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Will AI Replace Traditional CRO Models in Clinical Research?

The New Competitive Advantage in Life Sciences: Real-Time Data Intelligence

What Happens When AI Becomes a Scientific Co-Pilot?

Digital Twins in Healthcare: Hype, Reality, and Future Applications

Tag: Lilly

Lilly Licenses CSL’s Phase 3 IL-6 Antibody Clazakizumab in $100 Million Upfront Deal

Editor Picks

Merck invests $169 million for selective PARP1 medication

AstraZeneca Expands AI-Powered Immuno-Oncology Research Partnership with Immunai

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

Must Read

Will AI Replace Traditional CRO Models in Clinical Research?

The New Competitive Advantage in Life Sciences: Real-Time Data Intelligence

Following FDA hold, Aardvark will examine phase 3 data early

Hot Topics

About Us

Follow Us